CervoMed Inc. CRVO
- neflamapimod — Dementia with Lewy Bodies Phase 3
- neflamapimod — Frontotemporal Dementia Phase 2
p38α MAPK (1 companies · 2 programs)
Companies with an active program directed at p38α MAPK.
Companies with an active program directed at p38α MAPK.